newyorkensis-mediated 7-DHCA levels to suppress secondary BA biosynthesis, which in turn activated hepatic Nfil3-FXR-FGF15 signaling to ameliorate MASLD. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.